Medical Billing Code Search
What is a code?
8892 results found
| J1747 | Inj, spesolimab-sbzo, 1 mg | Description: Injection, spesolimab-sbzo, 1 mg |
| J1750 | Inj iron dextran | Description: Injection, iron dextran, 50 mg |
| J1756 | Iron sucrose injection | Description: Injection, iron sucrose, 1 mg |
| J1786 | Imuglucerase injection | Description: Injection, imiglucerase, 10 units |
| J1790 | Droperidol injection | Description: Injection, droperidol, up to 5 mg |
| J1800 | Propranolol injection | Description: Injection, propranolol hcl, up to 1 mg |
| J1805 | Inj, esmolol hcl, 10mg | Description: Injection, esmolol hydrochloride, 10 mg |
| J1811 | Fiasp for insulin pump use | Description: Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units |
| J1812 | Inj. insulin (fiasp) | Description: Insulin (fiasp), per 5 units |
| J1813 | Lyumjev for insulin pump use | Description: Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units |
| J1814 | Inj. insulin (lyumjev) | Description: Insulin (lyumjev), per 5 units |
| J1815 | Insulin injection | Description: Injection, insulin, per 5 units |
| J1817 | Insulin for insulin pump use | Description: Insulin for administration through dme (i.e., insulin pump) per 50 units |
| J1823 | Inj. inebilizumab-cdon, 1 mg | Description: Injection, inebilizumab-cdon, 1 mg |
| J1826 | Interferon beta-1a inj | Description: Injection, interferon beta-1a, 30 mcg |
| J1830 | Interferon beta-1b / .25 mg | Description: Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J1833 | Injection, isavuconazonium | Description: Injection, isavuconazonium, 1 mg |
| J1835 | Itraconazole injection | Description: Injection, itraconazole, 50 mg |
| J1836 | Inj, metronidazole, 10 mg | Description: Injection, metronidazole, 10 mg |
| J1840 | Kanamycin sulfate 500 mg inj | Description: Injection, kanamycin sulfate, up to 500 mg |
| J1850 | Kanamycin sulfate 75 mg inj | Description: Injection, kanamycin sulfate, up to 75 mg |
| J1885 | Ketorolac tromethamine inj | Description: Injection, ketorolac tromethamine, per 15 mg |
| J1920 | Inj, labetalol hcl, 5mg | Description: Injection, labetalol hydrochloride, 5 mg |
| J1930 | Lanreotide injection | Description: Injection, lanreotide, 1 mg |
| J1931 | Laronidase injection | Description: Injection, laronidase, 0.1 mg |
| J1932 | Inj, lanreotide, (cipla) 1mg | Description: Injection, lanreotide, (cipla), 1 mg |
| J1939 | Inj, bumetanide, 0.5 mg | Description: Injection, bumetanide, 0.5 mg |
| J1941 | Inj, furoscix, 20 mg | Description: Injection, furosemide (furoscix), 20 mg |
| J1943 | Inj., aristada initio, 1 mg | Description: Injection, aripiprazole lauroxil, (aristada initio), 1 mg |
| J1944 | Aripiprazole lauroxil 1 mg | Description: Injection, aripiprazole lauroxil, (aristada), 1 mg |
| J1945 | Lepirudin | Description: Injection, lepirudin, 50 mg |
| J1950 | Leuprolide acetate /3.75 mg | Description: Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
| J1951 | Inj fensolvi 0.25 mg | Description: Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg |
| J1952 | Leuprolide inj, camcevi, 1mg | Description: Leuprolide injectable, camcevi, 1 mg |
| J1953 | Levetiracetam injection | Description: Injection, levetiracetam, 10 mg |
| J1954 | Leuprolide depot cipla 7.5mg | Description: Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg |
| J1955 | Inj levocarnitine per 1 gm | Description: Injection, levocarnitine, per 1 gm |
| J1956 | Levofloxacin injection | Description: Injection, levofloxacin, 250 mg |
| J1960 | Levorphanol tartrate inj | Description: Injection, levorphanol tartrate, up to 2 mg |
| J1961 | Inj, lenacapavir, 1 mg | Description: Injection, lenacapavir, 1 mg |
| J1980 | Hyoscyamine sulfate inj | Description: Injection, hyoscyamine sulfate, up to 0.25 mg |
| J1990 | Chlordiazepoxide injection | Description: Injection, chlordiazepoxide hcl, up to 100 mg |
| J2010 | Lincomycin injection | Description: Injection, lincomycin hcl, up to 300 mg |
| J2020 | Linezolid injection | Description: Injection, linezolid, 200 mg |
| J2060 | Lorazepam injection | Description: Injection, lorazepam, 2 mg |
| J2062 | Loxapine for inhalation 1 mg | Description: Loxapine for inhalation, 1 mg |
| J2150 | Mannitol injection | Description: Injection, mannitol, 25% in 50 ml |
| J2170 | Mecasermin injection | Description: Injection, mecasermin, 1 mg |
| J2175 | Meperidine hydrochl /100 mg | Description: Injection, meperidine hydrochloride, per 100 mg |
| J2180 | Meperidine/promethazine inj | Description: Injection, meperidine and promethazine hcl, up to 50 mg |
| J2182 | Injection, mepolizumab, 1mg | Description: Injection, mepolizumab, 1 mg |
| J2185 | Meropenem | Description: Injection, meropenem, 100 mg |
| J2186 | Inj., meropenem, vaborbactam | Description: Injection, meropenem and vaborbactam, 10mg/10mg (20mg) |
| J2210 | Methylergonovin maleate inj | Description: Injection, methylergonovine maleate, up to 0.2 mg |
| J2212 | Methylnaltrexone injection | Description: Injection, methylnaltrexone, 0.1 mg |
| J2247 | Inj, micafungin (par pharm) | Description: Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg |
| J2248 | Micafungin sodium injection | Description: Injection, micafungin sodium, 1 mg |
| J2249 | Inj, remimazolam, 1 mg | Description: Injection, remimazolam, 1 mg |
| J2250 | Inj midazolam hydrochloride | Description: Injection, midazolam hydrochloride, per 1 mg |
| J2260 | Inj milrinone lactate / 5 mg | Description: Injection, milrinone lactate, 5 mg |
| J2265 | Minocycline hydrochloride | Description: Injection, minocycline hydrochloride, 1 mg |
| J2270 | Morphine sulfate injection | Description: Injection, morphine sulfate, up to 10 mg |
| J2274 | Inj morphine pf epid ithc | Description: Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
| J2278 | Ziconotide injection | Description: Injection, ziconotide, 1 microgram |
| J2280 | Inj, moxifloxacin 100 mg | Description: Injection, moxifloxacin, 100 mg |
| J2300 | Inj nalbuphine hydrochloride | Description: Injection, nalbuphine hydrochloride, per 10 mg |
| J2305 | Inj, nitroglycerin, 5 mg | Description: Injection, nitroglycerin, 5 mg |
| J2310 | Inj naloxone hydrochloride | Description: Injection, naloxone hydrochloride, per 1 mg |
| J2311 | Inj, naloxone hcl (zimhi) | Description: Injection, naloxone hydrochloride (zimhi), 1 mg |
| J2315 | Naltrexone, depot form | Description: Injection, naltrexone, depot form, 1 mg |
| J2320 | Nandrolone decanoate 50 mg | Description: Injection, nandrolone decanoate, up to 50 mg |
| J2323 | Natalizumab injection | Description: Injection, natalizumab, 1 mg |
| J2325 | Nesiritide injection | Description: Injection, nesiritide, 0.1 mg |
| J2326 | Inj, nusinersen, 0.1mg | Description: Injection, nusinersen, 0.1 mg |
| J2327 | Inj risankizumab-rzaa 1 mg | Description: Injection, risankizumab-rzaa, intravenous, 1 mg |
| J2329 | Inj ublituximab-xiiy, 1 mg | Description: Injection, ublituximab-xiiy, 1mg |
| J2350 | Injection, ocrelizumab, 1 mg | Description: Injection, ocrelizumab, 1 mg |
| J2353 | Octreotide injection, depot | Description: Injection, octreotide, depot form for intramuscular injection, 1 mg |
| J2354 | Octreotide inj, non-depot | Description: Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg |
| J2355 | Oprelvekin injection | Description: Injection, oprelvekin, 5 mg |
| J2356 | Inj tezepelumab-ekko, 1mg | Description: Injection, tezepelumab-ekko, 1 mg |
| J2357 | Omalizumab injection | Description: Injection, omalizumab, 5 mg |
| J2358 | Olanzapine long-acting inj | Description: Injection, olanzapine, long-acting, 1 mg |
| J2359 | Inj. olanzapine, 0.5mg | Description: Injection, olanzapine, 0.5 mg |
| J2360 | Orphenadrine injection | Description: Injection, orphenadrine citrate, up to 60 mg |
| J2371 | Inj phenylephrine hcl 20 mcg | Description: Injection, phenylephrine hydrochloride, 20 micrograms |
| J2372 | Inj, biorphen, 20 micrograms | Description: Injection, phenylephrine hydrochloride (biorphen), 20 micrograms |
| J2401 | Chloroprocaine hcl injection | Description: Injection, chloroprocaine hydrochloride, per 1 mg |
| J2402 | Chloroprocaine (clorotekal) | Description: Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg |
| J2403 | Chloroprocaine opht gel, 1mg | Description: Chloroprocaine hcl ophthalmic, 3% gel, 1 mg |
| J2404 | Inj, nicardipine 0.1 mg | Description: Injection, nicardipine, 0.1 mg |
| J2405 | Ondansetron hcl injection | Description: Injection, ondansetron hydrochloride, per 1 mg |
| J2406 | Injection, oritavancin 10 mg | Description: Injection, oritavancin (kimyrsa), 10 mg |
| J2407 | Injection, oritavancin | Description: Injection, oritavancin (orbactiv), 10 mg |
| J2410 | Oxymorphone hcl injection | Description: Injection, oxymorphone hcl, up to 1 mg |
| J2425 | Palifermin injection | Description: Injection, palifermin, 50 micrograms |
| J2426 | Inj, invega sustenna, 1 mg | Description: Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
| J2427 | Inj, invega hafyera/trinza | Description: Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg |
| J2430 | Pamidronate disodium /30 mg | Description: Injection, pamidronate disodium, per 30 mg |
| J2440 | Papaverin hcl injection | Description: Injection, papaverine hcl, up to 60 mg |
| J2460 | Oxytetracycline injection | Description: Injection, oxytetracycline hcl, up to 50 mg |
| J2469 | Palonosetron hcl | Description: Injection, palonosetron hcl, 25 mcg |
| J2501 | Paricalcitol | Description: Injection, paricalcitol, 1 mcg |
| J2502 | Inj, pasireotide long acting | Description: Injection, pasireotide long acting, 1 mg |
| J2503 | Pegaptanib sodium injection | Description: Injection, pegaptanib sodium, 0.3 mg |
| J2504 | Pegademase bovine, 25 iu | Description: Injection, pegademase bovine, 25 iu |
| J2506 | Inj pegfilgrast ex bio 0.5mg | Description: Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
| J2507 | Pegloticase injection | Description: Injection, pegloticase, 1 mg |
| J2508 | Pegunigalsidase alfa-iwxj | Description: Injection, pegunigalsidase alfa-iwxj, 1 mg |
| J2510 | Penicillin g procaine inj | Description: Injection, penicillin g procaine, aqueous, up to 600,000 units |
| J2513 | Pentastarch 10% solution | Description: Injection, pentastarch, 10% solution, 100 ml |
| J2515 | Pentobarbital sodium inj | Description: Injection, pentobarbital sodium, per 50 mg |
| J2540 | Penicillin g potassium inj | Description: Injection, penicillin g potassium, up to 600,000 units |
| J2543 | Piperacillin/tazobactam | Description: Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
| J2545 | Pentamidine non-comp unit | Description: Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg |
| J2547 | Injection, peramivir | Description: Injection, peramivir, 1 mg |
| J2550 | Promethazine hcl injection | Description: Injection, promethazine hcl, up to 50 mg |
| J2560 | Phenobarbital sodium inj | Description: Injection, phenobarbital sodium, up to 120 mg |
| J2561 | Inj, sezaby, 1 mg | Description: Injection, phenobarbital sodium (sezaby), 1 mg |
| J2562 | Plerixafor injection | Description: Injection, plerixafor, 1 mg |
| J2590 | Oxytocin injection | Description: Injection, oxytocin, up to 10 units |
| J2597 | Inj desmopressin acetate | Description: Injection, desmopressin acetate, per 1 mcg |
| J2598 | Inj, vasopressin, 1 unit | Description: Injection, vasopressin, 1 unit |
| J2650 | Prednisolone acetate inj | Description: Injection, prednisolone acetate, up to 1 ml |
| J2670 | Totazoline hcl injection | Description: Injection, tolazoline hcl, up to 25 mg |
| J2675 | Inj progesterone per 50 mg | Description: Injection, progesterone, per 50 mg |
| J2679 | Inj fluphenazine hcl 1.25 mg | Description: Injection, fluphenazine hcl, 1.25 mg |
| J2680 | Fluphenazine decanoate 25 mg | Description: Injection, fluphenazine decanoate, up to 25 mg |
| J2690 | Procainamide hcl injection | Description: Injection, procainamide hcl, up to 1 gm |
| J2700 | Oxacillin sodium injeciton | Description: Injection, oxacillin sodium, up to 250 mg |
| J2704 | Inj, propofol, 10 mg | Description: Injection, propofol, 10 mg |
| J2710 | Neostigmine methylslfte inj | Description: Injection, neostigmine methylsulfate, up to 0.5 mg |
| J2720 | Inj protamine sulfate/10 mg | Description: Injection, protamine sulfate, per 10 mg |
| J2724 | Protein c concentrate | Description: Injection, protein c concentrate, intravenous, human, 10 iu |
| J2725 | Inj protirelin per 250 mcg | Description: Injection, protirelin, per 250 mcg |
| J2730 | Pralidoxime chloride inj | Description: Injection, pralidoxime chloride, up to 1 gm |
| J2760 | Phentolaine mesylate inj | Description: Injection, phentolamine mesylate, up to 5 mg |
| J2765 | Metoclopramide hcl injection | Description: Injection, metoclopramide hcl, up to 10 mg |
| J2770 | Quinupristin/dalfopristin | Description: Injection, quinupristin/dalfopristin, 500 mg (150/350) |
| J2777 | Inj, faricimab-svoa, 0.1mg | Description: Injection, faricimab-svoa, 0.1 mg |
| J2778 | Ranibizumab injection | Description: Injection, ranibizumab, 0.1 mg |
| J2779 | Inj, susvimo 0.1 mg | Description: Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg |
| J2781 | Inj, pegcetacoplan, 1mg | Description: Injection, pegcetacoplan, intravitreal, 1 mg |
| J2783 | Rasburicase | Description: Injection, rasburicase, 0.5 mg |
| J2785 | Regadenoson injection | Description: Injection, regadenoson, 0.1 mg |
| J2786 | Injection, reslizumab, 1mg | Description: Injection, reslizumab, 1 mg |
| J2787 | Riboflavin 5'phos opth<=3ml | Description: Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml |
| J2788 | Rho d immune globulin 50 mcg | Description: Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) |
| J2790 | Rho d immune globulin inj | Description: Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
| J2791 | Rhophylac injection | Description: Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
| J2792 | Rho(d) immune globulin h, sd | Description: Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu |
| J2793 | Rilonacept injection | Description: Injection, rilonacept, 1 mg |
| J2794 | Inj risperdal consta, 0.5 mg | Description: Injection, risperidone (risperdal consta), 0.5 mg |
| J2795 | Ropivacaine hcl injection | Description: Injection, ropivacaine hydrochloride, 1 mg |
| J2797 | Inj., rolapitant, 0.5 mg | Description: Injection, rolapitant, 0.5 mg |
| J2798 | Inj., perseris, 0.5 mg | Description: Injection, risperidone, (perseris), 0.5 mg |
| J2799 | Inj, uzedy, 1 mg | Description: Injection, risperidone (uzedy), 1 mg |
| J2800 | Methocarbamol injection | Description: Injection, methocarbamol, up to 10 ml |
| J2805 | Sincalide injection | Description: Injection, sincalide, 5 micrograms |
| J2810 | Inj theophylline per 40 mg | Description: Injection, theophylline, per 40 mg |
| J2820 | Sargramostim injection | Description: Injection, sargramostim (gm-csf), 50 mcg |
| J2840 | Inj sebelipase alfa 1 mg | Description: Injection, sebelipase alfa, 1 mg |
| J2850 | Inj secretin synthetic human | Description: Injection, secretin, synthetic, human, 1 microgram |
| J2860 | Injection, siltuximab | Description: Injection, siltuximab, 10 mg |
| J2910 | Aurothioglucose injeciton | Description: Injection, aurothioglucose, up to 50 mg |
| J2916 | Na ferric gluconate complex | Description: Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
| J2920 | Methylprednisolone injection | Description: Injection, methylprednisolone sodium succinate, up to 40 mg |
| J2930 | Methylprednisolone injection | Description: Injection, methylprednisolone sodium succinate, up to 125 mg |
| J2940 | Somatrem injection | Description: Injection, somatrem, 1 mg |
| J2941 | Somatropin injection | Description: Injection, somatropin, 1 mg |
| J2950 | Promazine hcl injection | Description: Injection, promazine hcl, up to 25 mg |
| J2993 | Reteplase injection | Description: Injection, reteplase, 18.1 mg |
| J2995 | Inj streptokinase /250000 iu | Description: Injection, streptokinase, per 250,000 iu |
| J2997 | Alteplase recombinant | Description: Injection, alteplase recombinant, 1 mg |
| J2998 | Inj plasminogen tvmh 1mg | Description: Injection, plasminogen, human-tvmh, 1 mg |
| J3000 | Streptomycin injection | Description: Injection, streptomycin, up to 1 gm |
| J3010 | Fentanyl citrate injection | Description: Injection, fentanyl citrate, 0.1 mg |
| J3030 | Sumatriptan succinate / 6 mg | Description: Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
| J3031 | Inj., fremanezumab-vfrm 1 mg | Description: Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
| J3032 | Inj. eptinezumab-jjmr 1 mg | Description: Injection, eptinezumab-jjmr, 1 mg |
| J3060 | Inj, taliglucerase alfa 10 u | Description: Injection, taliglucerase alfa, 10 units |
| J3070 | Pentazocine injection | Description: Injection, pentazocine, 30 mg |
| J3090 | Inj tedizolid phosphate | Description: Injection, tedizolid phosphate, 1 mg |
| J3095 | Telavancin injection | Description: Injection, telavancin, 10 mg |
| J3101 | Tenecteplase injection | Description: Injection, tenecteplase, 1 mg |
| J3105 | Terbutaline sulfate inj | Description: Injection, terbutaline sulfate, up to 1 mg |
| J3110 | Teriparatide injection | Description: Injection, teriparatide, 10 mcg |
| J3111 | Inj. romosozumab-aqqg 1 mg | Description: Injection, romosozumab-aqqg, 1 mg |
| J3121 | Inj testostero enanthate 1mg | Description: Injection, testosterone enanthate, 1 mg |
| J3145 | Testosterone undecanoate 1mg | Description: Injection, testosterone undecanoate, 1 mg |
| J3230 | Chlorpromazine hcl injection | Description: Injection, chlorpromazine hcl, up to 50 mg |
| J3240 | Thyrotropin injection | Description: Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial |
| J3241 | Inj. teprotumumab-trbw 10 mg | Description: Injection, teprotumumab-trbw, 10 mg |
| J3243 | Tigecycline injection | Description: Injection, tigecycline, 1 mg |
| J3245 | Inj., tildrakizumab, 1 mg | Description: Injection, tildrakizumab, 1 mg |
| J3246 | Tirofiban hcl | Description: Injection, tirofiban hcl, 0.25 mg |
| J3250 | Trimethobenzamide hcl inj | Description: Injection, trimethobenzamide hcl, up to 200 mg |
| J3260 | Tobramycin sulfate injection | Description: Injection, tobramycin sulfate, up to 80 mg |
| J3262 | Tocilizumab injection | Description: Injection, tocilizumab, 1 mg |
| J3265 | Injection torsemide 10 mg/ml | Description: Injection, torsemide, 10 mg/ml |
| J3280 | Thiethylperazine maleate inj | Description: Injection, thiethylperazine maleate, up to 10 mg |
| J3285 | Treprostinil injection | Description: Injection, treprostinil, 1 mg |
| J3299 | Inj xipere 1 mg | Description: Injection, triamcinolone acetonide (xipere), 1 mg |
| J3300 | Triamcinolone a inj prs-free | Description: Injection, triamcinolone acetonide, preservative free, 1 mg |
| J3301 | Triamcinolone acet inj nos | Description: Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
| J3302 | Triamcinolone diacetate inj | Description: Injection, triamcinolone diacetate, per 5 mg |
| J3303 | Triamcinolone hexacetonl inj | Description: Injection, triamcinolone hexacetonide, per 5 mg |
| J3304 | Inj triamcinolone ace xr 1mg | Description: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg |
| J3305 | Inj trimetrexate glucoronate | Description: Injection, trimetrexate glucuronate, per 25 mg |
| J3310 | Perphenazine injeciton | Description: Injection, perphenazine, up to 5 mg |
| J3315 | Triptorelin pamoate | Description: Injection, triptorelin pamoate, 3.75 mg |
| J3316 | Inj., triptorelin xr 3.75 mg | Description: Injection, triptorelin, extended-release, 3.75 mg |
| J3320 | Spectinomycn di-hcl inj | Description: Injection, spectinomycin dihydrochloride, up to 2 gm |
| J3350 | Urea injection | Description: Injection, urea, up to 40 gm |
| J3355 | Urofollitropin, 75 iu | Description: Injection, urofollitropin, 75 iu |
| J3357 | Ustekinumab sub cu inj, 1 mg | Description: Ustekinumab, for subcutaneous injection, 1 mg |
| J3358 | Ustekinumab, iv inject, 1 mg | Description: Ustekinumab, for intravenous injection, 1 mg |
| J3360 | Diazepam injection | Description: Injection, diazepam, up to 5 mg |
| J3364 | Urokinase 5000 iu injection | Description: Injection, urokinase, 5000 iu vial |
| J3365 | Urokinase 250,000 iu inj | Description: Injection, iv, urokinase, 250,000 i.u. vial |
| J3370 | Vancomycin hcl injection | Description: Injection, vancomycin hcl, 500 mg |
| J3380 | Injection, vedolizumab | Description: Injection, vedolizumab, 1 mg |
| J3385 | Velaglucerase alfa | Description: Injection, velaglucerase alfa, 100 units |
| J3396 | Verteporfin injection | Description: Injection, verteporfin, 0.1 mg |
| J3397 | Inj., vestronidase alfa-vjbk | Description: Injection, vestronidase alfa-vjbk, 1 mg |
| J3398 | Inj luxturna 1 billion vec g | Description: Injection, voretigene neparvovec-rzyl, 1 billion vector genomes |
| J3399 | Inj onase abepar-xioi treat | Description: Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes |
| J3400 | Triflupromazine hcl inj | Description: Injection, triflupromazine hcl, up to 20 mg |
| J3401 | Vyjuvek 5x10^9pfu/ml, 0.1 ml | Description: Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml |
| J3410 | Hydroxyzine hcl injection | Description: Injection, hydroxyzine hcl, up to 25 mg |
| J3411 | Thiamine hcl 100 mg | Description: Injection, thiamine hcl, 100 mg |
| J3415 | Pyridoxine hcl 100 mg | Description: Injection, pyridoxine hcl, 100 mg |
| J3420 | Vitamin b12 injection | Description: Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
| J3425 | Inj, hydroxocobalamin | Description: Injection, hydroxocobalamin, 10 mcg |
| J3430 | Vitamin k phytonadione inj | Description: Injection, phytonadione (vitamin k), per 1 mg |
| J3465 | Injection, voriconazole | Description: Injection, voriconazole, 10 mg |
| J3470 | Hyaluronidase injection | Description: Injection, hyaluronidase, up to 150 units |
| J3471 | Ovine, up to 999 usp units | Description: Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) |
| J3472 | Ovine, 1000 usp units | Description: Injection, hyaluronidase, ovine, preservative free, per 1000 usp units |
| J3473 | Hyaluronidase recombinant | Description: Injection, hyaluronidase, recombinant, 1 usp unit |
| J3475 | Inj magnesium sulfate | Description: Injection, magnesium sulfate, per 500 mg |
| J3480 | Inj potassium chloride | Description: Injection, potassium chloride, per 2 meq |
| J3485 | Zidovudine | Description: Injection, zidovudine, 10 mg |
| J3486 | Ziprasidone mesylate | Description: Injection, ziprasidone mesylate, 10 mg |
| J3489 | Zoledronic acid 1mg | Description: Injection, zoledronic acid, 1 mg |
| J3490 | Drugs unclassified injection | Description: Unclassified drugs |
| J3520 | Edetate disodium per 150 mg | Description: Edetate disodium, per 150 mg |
| J3530 | Nasal vaccine inhalation | Description: Nasal vaccine inhalation |
| J3535 | Metered dose inhaler drug | Description: Drug administered through a metered dose inhaler |
| J3570 | Laetrile amygdalin vit b17 | Description: Laetrile, amygdalin, vitamin b17 |
| J3590 | Unclassified biologics | Description: Unclassified biologics |
| J3591 | Esrd on dialysi drug/bio noc | Description: Unclassified drug or biological used for esrd on dialysis |
| J7030 | Normal saline solution infus | Description: Infusion, normal saline solution , 1000 cc |
| J7040 | Normal saline solution infus | Description: Infusion, normal saline solution, sterile (500 ml = 1 unit) |
| J7042 | 5% dextrose/normal saline | Description: 5% dextrose/normal saline (500 ml = 1 unit) |
| J7050 | Normal saline solution infus | Description: Infusion, normal saline solution, 250 cc |
| J7060 | 5% dextrose/water | Description: 5% dextrose/water (500 ml = 1 unit) |
| J7070 | D5w infusion | Description: Infusion, d5w, 1000 cc |
| J7100 | Dextran 40 infusion | Description: Infusion, dextran 40, 500 ml |
| J7110 | Dextran 75 infusion | Description: Infusion, dextran 75, 500 ml |
| J7120 | Ringers lactate infusion | Description: Ringers lactate infusion, up to 1000 cc |
| J7121 | 5% dextrose in lac ringers | Description: 5% dextrose in lactated ringers infusion, up to 1000 cc |
| J7131 | Hypertonic saline sol | Description: Hypertonic saline solution, 1 ml |
| J7168 | Prothrombin complex kcentra | Description: Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity |
| J7169 | Inj andexxa, 10 mg | Description: Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg |
| J7170 | Inj., emicizumab-kxwh 0.5 mg | Description: Injection, emicizumab-kxwh, 0.5 mg |
| J7175 | Inj, factor x, (human), 1iu | Description: Injection, factor x, (human), 1 i.u. |
| J7177 | Inj., fibryga, 1 mg | Description: Injection, human fibrinogen concentrate (fibryga), 1 mg |
| J7178 | Inj human fibrinogen con nos | Description: Injection, human fibrinogen concentrate, not otherwise specified, 1 mg |
| J7179 | Vonvendi inj 1 iu vwf:rco | Description: Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco |
| J7180 | Factor xiii anti-hem factor | Description: Injection, factor xiii (antihemophilic factor, human), 1 i.u. |
| J7181 | Factor xiii recomb a-subunit | Description: Injection, factor xiii a-subunit, (recombinant), per iu |
| J7182 | Factor viii recomb novoeight | Description: Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu |
| J7183 | Wilate injection | Description: Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco |
| J7185 | Xyntha inj | Description: Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u. |
| J7186 | Antihemophilic viii/vwf comp | Description: Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u. |
| J7187 | Humate-p, inj | Description: Injection, von willebrand factor complex (humate-p), per iu vwf:rco |
| J7188 | Factor viii recomb obizur | Description: Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u. |
| J7189 | Factor viia recomb novoseven | Description: Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram |
| J7190 | Factor viii | Description: Factor viii (antihemophilic factor, human) per i.u. |
| J7191 | Factor viii (porcine) | Description: Factor viii (antihemophilic factor (porcine)), per i.u. |
| J7192 | Factor viii recombinant nos | Description: Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified |
| J7193 | Factor ix non-recombinant | Description: Factor ix (antihemophilic factor, purified, non-recombinant) per i.u. |
| J7194 | Factor ix complex | Description: Factor ix, complex, per i.u. |
| J7195 | Factor ix recombinant nos | Description: Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified |
| J7196 | Antithrombin recombinant | Description: Injection, antithrombin recombinant, 50 i.u. |
| J7197 | Antithrombin iii injection | Description: Antithrombin iii (human), per i.u. |
| J7198 | Anti-inhibitor | Description: Anti-inhibitor, per i.u. |
| J7199 | Hemophilia clot factor noc | Description: Hemophilia clotting factor, not otherwise classified |
| J7200 | Factor ix recombinan rixubis | Description: Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu |
| J7201 | Factor ix alprolix recomb | Description: Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u. |
| J7202 | Factor ix idelvion inj | Description: Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u. |
| J7203 | Factor ix recomb gly rebinyn | Description: Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu |
| J7204 | Inj recombin esperoct per iu | Description: Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu |
| J7205 | Factor viii fc fusion recomb | Description: Injection, factor viii fc fusion protein (recombinant), per iu |
| J7207 | Factor viii pegylated recomb | Description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u. |
| J7208 | Inj. jivi 1 iu | Description: Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u. |
| J7209 | Factor viii nuwiq recomb 1iu | Description: Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u. |
| J7210 | Inj, afstyla, 1 i.u. | Description: Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u. |
| J7211 | Inj, kovaltry, 1 i.u. | Description: Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u. |
| J7212 | Factor viia recomb sevenfact | Description: Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram |
| J7213 | Inj, ixinity, 1 i.u. | Description: Injection, coagulation factor ix (recombinant), ixinity, 1 i.u. |
| J7214 | Altuviiio per factor viii iu | Description: Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u. |
| J7294 | Seg acet and eth estr yearly | Description: Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each |
| J7295 | Eth estr and eton monthly | Description: Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each |
| J7296 | Kyleena, 19.5 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg |
| J7297 | Liletta, 52 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
| J7298 | Mirena, 52 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
| J7300 | Intraut copper contraceptive | Description: Intrauterine copper contraceptive |
| J7301 | Skyla, 13.5 mg | Description: Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg |
| J7304 | Contraceptive hormone patch | Description: Contraceptive supply, hormone containing patch, each |
| J7306 | Levonorgestrel implant sys | Description: Levonorgestrel (contraceptive) implant system, including implants and supplies |
| J7307 | Etonogestrel implant system | Description: Etonogestrel (contraceptive) implant system, including implant and supplies |
| J7308 | Aminolevulinic acid hcl top | Description: Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) |
| J7309 | Methyl aminolevulinate, top | Description: Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram |
| J7310 | Ganciclovir long act implant | Description: Ganciclovir, 4.5 mg, long-acting implant |
| J7311 | Inj., retisert, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg |
| J7312 | Dexamethasone intra implant | Description: Injection, dexamethasone, intravitreal implant, 0.1 mg |
| J7313 | Inj., iluvien, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg |
| J7314 | Inj., yutiq, 0.01 mg | Description: Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg |
| J7315 | Ophthalmic mitomycin | Description: Mitomycin, ophthalmic, 0.2 mg |
| J7316 | Inj, ocriplasmin, 0.125 mg | Description: Injection, ocriplasmin, 0.125 mg |
| J7318 | Inj, durolane 1 mg | Description: Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg |
| J7320 | Genvisc 850, inj, 1mg | Description: Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg |
| J7321 | Hyalgan supartz visco-3 dose | Description: Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose |
| J7322 | Hymovis injection 1 mg | Description: Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg |
| J7323 | Euflexxa inj per dose | Description: Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
| J7324 | Orthovisc inj per dose | Description: Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose |
| J7325 | Synvisc or synvisc-one | Description: Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
| J7326 | Gel-one | Description: Hyaluronan or derivative, gel-one, for intra-articular injection, per dose |
| J7327 | Monovisc inj per dose | Description: Hyaluronan or derivative, monovisc, for intra-articular injection, per dose |
| J7328 | Gelsyn-3 injection 0.1 mg | Description: Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg |
| J7329 | Inj, trivisc 1 mg | Description: Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg |
| J7330 | Cultured chondrocytes implnt | Description: Autologous cultured chondrocytes, implant |
| J7331 | Synojoynt, inj., 1 mg | Description: Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg |
| J7332 | Inj., triluron, 1 mg | Description: Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg |
| J7336 | Capsaicin 8% patch | Description: Capsaicin 8% patch, per square centimeter |
| J7340 | Carbidopa levodopa ent 100ml | Description: Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml |
| J7342 | Ciprofloxacin otic susp 6 mg | Description: Instillation, ciprofloxacin otic suspension, 6 mg |
| J7345 | Aminolevulinic acid, 10% gel | Description: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg |
| J7351 | Inj bimatoprost itc imp1mcg | Description: Injection, bimatoprost, intracameral implant, 1 microgram |
| J7352 | Afamelanotide implant, 1 mg | Description: Afamelanotide implant, 1 mg |
| J7353 | Anacaulase-bcdb 8.8% gel 1 g | Description: Anacaulase-bcdb, 8.8% gel, 1 gram |
| J7402 | Mometasone sinus sinuva | Description: Mometasone furoate sinus implant, (sinuva), 10 micrograms |
| J7500 | Azathioprine oral 50mg | Description: Azathioprine, oral, 50 mg |
| J7501 | Azathioprine parenteral | Description: Azathioprine, parenteral, 100 mg |
| J7502 | Cyclosporine oral 100 mg | Description: Cyclosporine, oral, 100 mg |
| J7503 | Tacrol envarsus ex rel oral | Description: Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg |
| J7504 | Lymphocyte immune globulin | Description: Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg |
| J7505 | Monoclonal antibodies | Description: Muromonab-cd3, parenteral, 5 mg |
| J7507 | Tacrolimus imme rel oral 1mg | Description: Tacrolimus, immediate release, oral, 1 mg |
| J7508 | Tacrol astagraf ex rel oral | Description: Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg |
| J7509 | Methylprednisolone oral | Description: Methylprednisolone oral, per 4 mg |
| J7510 | Prednisolone oral per 5 mg | Description: Prednisolone oral, per 5 mg |
| J7511 | Antithymocyte globuln rabbit | Description: Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg |
| J7512 | Prednisone ir or dr oral 1mg | Description: Prednisone, immediate release or delayed release, oral, 1 mg |
| J7513 | Daclizumab, parenteral | Description: Daclizumab, parenteral, 25 mg |
| J7515 | Cyclosporine oral 25 mg | Description: Cyclosporine, oral, 25 mg |
| J7516 | Cyclosporin parenteral 250mg | Description: Cyclosporin, parenteral, 250 mg |
| J7517 | Mycophenolate mofetil oral | Description: Mycophenolate mofetil, oral, 250 mg |
| J7518 | Mycophenolic acid | Description: Mycophenolic acid, oral, 180 mg |
| J7519 | Inj. mycophenolate mofetil | Description: Injection, mycophenolate mofetil, 10 mg |
| J7520 | Sirolimus, oral | Description: Sirolimus, oral, 1 mg |
| J7525 | Tacrolimus injection | Description: Tacrolimus, parenteral, 5 mg |
| J7527 | Oral everolimus | Description: Everolimus, oral, 0.25 mg |
| J7599 | Immunosuppressive drug noc | Description: Immunosuppressive drug, not otherwise classified |
| J7604 | Acetylcysteine comp unit | Description: Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram |
| J7605 | Arformoterol non-comp unit | Description: Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
| J7606 | Formoterol fumarate, inh | Description: Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms |
| J7607 | Levalbuterol comp con | Description: Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg |
| J7608 | Acetylcysteine non-comp unit | Description: Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram |
| J7609 | Albuterol comp unit | Description: Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
| J7610 | Albuterol comp con | Description: Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
| J7611 | Albuterol non-comp con | Description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
| J7612 | Levalbuterol non-comp con | Description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg |
| J7613 | Albuterol non-comp unit | Description: Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
| J7614 | Levalbuterol non-comp unit | Description: Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
| J7615 | Levalbuterol comp unit | Description: Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg |
| J7620 | Albuterol ipratrop non-comp | Description: Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
| J7622 | Beclomethasone comp unit | Description: Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7624 | Betamethasone comp unit | Description: Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7626 | Budesonide non-comp unit | Description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
| J7627 | Budesonide comp unit | Description: Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg |
| J7628 | Bitolterol mesylate comp con | Description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7629 | Bitolterol mesylate comp unt | Description: Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7631 | Cromolyn sodium noncomp unit | Description: Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7632 | Cromolyn sodium comp unit | Description: Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7633 | Budesonide non-comp con | Description: Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
| J7634 | Budesonide comp con | Description: Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram |
| J7635 | Atropine comp con | Description: Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7636 | Atropine comp unit | Description: Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7637 | Dexamethasone comp con | Description: Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7638 | Dexamethasone comp unit | Description: Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7639 | Dornase alfa non-comp unit | Description: Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7640 | Formoterol comp unit | Description: Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms |
| J7641 | Flunisolide comp unit | Description: Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram |
| J7642 | Glycopyrrolate comp con | Description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7643 | Glycopyrrolate comp unit | Description: Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7644 | Ipratropium bromide non-comp | Description: Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7645 | Ipratropium bromide comp | Description: Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7647 | Isoetharine comp con | Description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7648 | Isoetharine non-comp con | Description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7649 | Isoetharine non-comp unit | Description: Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7650 | Isoetharine comp unit | Description: Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7657 | Isoproterenol comp con | Description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7658 | Isoproterenol non-comp con | Description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram |
| J7659 | Isoproterenol non-comp unit | Description: Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
| J7660 | Isoproterenol comp unit | Description: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7665 | Mannitol for inhaler | Description: Mannitol, administered through an inhaler, 5 mg |
| J7667 | Metaproterenol comp con | Description: Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams |
| J7668 | Metaproterenol non-comp con | Description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams |
| J7669 | Metaproterenol non-comp unit | Description: Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams |
| J7670 | Metaproterenol comp unit | Description: Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams |
| J7674 | Methacholine chloride, neb | Description: Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
| J7676 | Pentamidine comp unit dose | Description: Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg |
| J7677 | Revefenacin inh non-com 1mcg | Description: Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram |
| J7680 | Terbutaline sulf comp con | Description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7681 | Terbutaline sulf comp unit | Description: Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7682 | Tobramycin non-comp unit | Description: Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams |
| J7683 | Triamcinolone comp con | Description: Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram |
| J7684 | Triamcinolone comp unit | Description: Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram |
| J7685 | Tobramycin comp unit | Description: Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams |
| J7686 | Treprostinil, non-comp unit | Description: Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg |
| J7699 | Inhalation solution for dme | Description: Noc drugs, inhalation solution administered through dme |
| J7799 | Non-inhalation drug for dme | Description: Noc drugs, other than inhalation drugs, administered through dme |
| J7999 | Compounded drug, noc | Description: Compounded drug, not otherwise classified |
| J8498 | Antiemetic rectal/supp nos | Description: Antiemetic drug, rectal/suppository, not otherwise specified |
| J8499 | Oral prescrip drug non chemo | Description: Prescription drug, oral, non chemotherapeutic, nos |
| J8501 | Oral aprepitant | Description: Aprepitant, oral, 5 mg |
| J8510 | Oral busulfan | Description: Busulfan; oral, 2 mg |
| J8515 | Cabergoline, oral 0.25mg | Description: Cabergoline, oral, 0.25 mg |
| J8530 | Cyclophosphamide oral 25 mg | Description: Cyclophosphamide; oral, 25 mg |
| J8540 | Oral dexamethasone | Description: Dexamethasone, oral, 0.25 mg |
| J8560 | Etoposide oral 50 mg | Description: Etoposide; oral, 50 mg |
| J8562 | Oral fludarabine phosphate | Description: Fludarabine phosphate, oral, 10 mg |
| J8565 | Gefitinib oral | Description: Gefitinib, oral, 250 mg |
| J8597 | Antiemetic drug oral nos | Description: Antiemetic drug, oral, not otherwise specified |
| J8600 | Melphalan oral 2 mg | Description: Melphalan; oral, 2 mg |
| J8610 | Methotrexate oral 2.5 mg | Description: Methotrexate; oral, 2.5 mg |
| J8650 | Nabilone oral | Description: Nabilone, oral, 1 mg |
| J8655 | Oral netupitant, palonosetro | Description: Netupitant 300 mg and palonosetron 0.5 mg, oral |
| J8670 | Rolapitant, oral, 1mg | Description: Rolapitant, oral, 1 mg |
| J8700 | Temozolomide | Description: Temozolomide, oral, 5 mg |
| J8705 | Topotecan oral | Description: Topotecan, oral, 0.25 mg |
| J8999 | Oral prescription drug chemo | Description: Prescription drug, oral, chemotherapeutic, nos |
| J9000 | Doxorubicin hcl injection | Description: Injection, doxorubicin hydrochloride, 10 mg |
| J9015 | Aldesleukin injection | Description: Injection, aldesleukin, per single use vial |
| J9017 | Arsenic trioxide injection | Description: Injection, arsenic trioxide, 1 mg |
| J9019 | Erwinaze injection | Description: Injection, asparaginase (erwinaze), 1,000 iu |
| J9020 | Asparaginase, nos | Description: Injection, asparaginase, not otherwise specified, 10,000 units |
| J9021 | Inj, aspara, rylaze, 0.1 mg | Description: Injection, asparaginase, recombinant, (rylaze), 0.1 mg |
| J9022 | Inj, atezolizumab,10 mg | Description: Injection, atezolizumab, 10 mg |
| J9023 | Injection, avelumab, 10 mg | Description: Injection, avelumab, 10 mg |
| J9025 | Azacitidine injection | Description: Injection, azacitidine, 1 mg |
| J9027 | Clofarabine injection | Description: Injection, clofarabine, 1 mg |
| J9029 | Inj, adstiladrin, per tx dos | Description: Injection, nadofaragene firadenovec-vncg, per therapeutic dose |
| J9030 | Bcg live intravesical 1mg | Description: Bcg live intravesical instillation, 1 mg |
| J9032 | Injection, belinostat, 10mg | Description: Injection, belinostat, 10 mg |
| J9034 | Inj., bendeka 1 mg | Description: Injection, bendamustine hcl (bendeka), 1 mg |
| J9035 | Bevacizumab injection | Description: Injection, bevacizumab, 10 mg |
| J9036 | Inj. belrapzo/bendamustine | Description: Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg |
| J9039 | Injection, blinatumomab | Description: Injection, blinatumomab, 1 microgram |
| J9040 | Bleomycin sulfate injection | Description: Injection, bleomycin sulfate, 15 units |
| J9041 | Injection, bortezomib, 0.1mg | Description: Injection, bortezomib, 0.1 mg |
| J9042 | Brentuximab vedotin inj | Description: Injection, brentuximab vedotin, 1 mg |
| J9043 | Cabazitaxel injection | Description: Injection, cabazitaxel, 1 mg |
| J9045 | Carboplatin injection | Description: Injection, carboplatin, 50 mg |
| J9047 | Injection, carfilzomib, 1 mg | Description: Injection, carfilzomib, 1 mg |
| J9048 | Inj, bortezomib freseniuskab | Description: Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg |
| J9049 | Inj, bortezomib, hospira | Description: Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg |
| J9050 | Carmustine injection | Description: Injection, carmustine, 100 mg |
| J9051 | Inj, bortezomib (maia) | Description: Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg |
| J9052 | Inj, carmustine (accord) | Description: Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg |
| J9055 | Cetuximab injection | Description: Injection, cetuximab, 10 mg |
| J9057 | Inj., copanlisib, 1 mg | Description: Injection, copanlisib, 1 mg |
| J9060 | Cisplatin 10 mg injection | Description: Injection, cisplatin, powder or solution, 10 mg |
| J9061 | Inj, amivantamab-vmjw | Description: Injection, amivantamab-vmjw, 2 mg |
| J9063 | Inj, elahere, 1 mg | Description: Injection, mirvetuximab soravtansine-gynx, 1 mg |
| J9064 | Inj, cabazitaxel (sandoz) | Description: Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg |
| J9065 | Inj cladribine per 1 mg | Description: Injection, cladribine, per 1 mg |
| J9070 | Cyclophosphamide 100 mg inj | Description: Cyclophosphamide, 100 mg |
| J9071 | Inj cyclophosphamd auromedic | Description: Injection, cyclophosphamide, (auromedics), 5 mg |
| J9098 | Cytarabine liposome inj | Description: Injection, cytarabine liposome, 10 mg |
| J9100 | Cytarabine hcl 100 mg inj | Description: Injection, cytarabine, 100 mg |
| J9118 | Inj. calaspargase pegol-mknl | Description: Injection, calaspargase pegol-mknl, 10 units |
| J9119 | Inj., cemiplimab-rwlc, 1 mg | Description: Injection, cemiplimab-rwlc, 1 mg |
| J9120 | Dactinomycin injection | Description: Injection, dactinomycin, 0.5 mg |
| J9130 | Dacarbazine 100 mg inj | Description: Dacarbazine, 100 mg |
| J9144 | Daratumumab, hyaluronidase | Description: Injection, daratumumab, 10 mg and hyaluronidase-fihj |
| J9145 | Injection, daratumumab 10 mg | Description: Injection, daratumumab, 10 mg |
| J9150 | Daunorubicin injection | Description: Injection, daunorubicin, 10 mg |
| J9151 | Daunorubicin citrate inj | Description: Injection, daunorubicin citrate, liposomal formulation, 10 mg |
| J9153 | Inj daunorubicin, cytarabine | Description: Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
| J9155 | Degarelix injection | Description: Injection, degarelix, 1 mg |
| J9165 | Diethylstilbestrol injection | Description: Injection, diethylstilbestrol diphosphate, 250 mg |
| J9171 | Docetaxel injection | Description: Injection, docetaxel, 1 mg |
| J9173 | Inj., durvalumab, 10 mg | Description: Injection, durvalumab, 10 mg |
| J9175 | Elliotts b solution per ml | Description: Injection, elliotts' b solution, 1 ml |
| J9176 | Injection, elotuzumab, 1mg | Description: Injection, elotuzumab, 1 mg |
| J9177 | Inj enfort vedo-ejfv 0.25mg | Description: Injection, enfortumab vedotin-ejfv, 0.25 mg |